HLA-C and neoplasm: Neoantigen-specific TCRs (NeoTCR), due to their central tolerance, exhibit a higher affinity for mutated p-MHC with stronger interaction and stability [38, 39], and their ability to induce tumor regression has been characterized in various refractory solid tumors originating from different types of somatic cell mutations [27, 29, 31, 40].